Abstract Search

ea0073aep816 | Late Breaking | ECE2021

24-week impact of dapagliflozin treatment on body weight, body composition, and cardiac risk indicators of patients with type-2 diabetes mellitus

Akhanli Pinar , Hepsen Sema , Emre Arslan Ismail , Duger Hakan , Bostan Hayri , Kizilgul Muhammed , Ucan Bekir , Cakal Erman

AimsWe aimed to reveal the impacts of dapagliflozin, a sodium glucose transporter inhibitor (SGLT2i), on the body weight and body composition, cardiovascular risk indexes, and carotis intima-media thickness (CIMT).MethodsBody weights, body compositions measured by means of bioelectrical impedance, and CIMT in the baseline, the 12th, and the 24th week of 42 patients with type-2 diabetes mellitus receiving SGLT...

0 shares

ea0073aep873 | Late Breaking | ECE2021

Changes in thyroid hormones and free triiodothyronine-to-free thyroxine ratio in euthyroid patients with obesity in terms of different glucose metabolism statuses

Hepsen Sema , Akhanli Pinar , Erkam Sencar Muhammed , Duger Hakan , Bostan Hayri , Kizilgul Muhammed , Emre Arslan Ismail , Cakal Erman

PurposeThyroid hormones are known to have an essential role in the regulation of energy homeostasis and glucose metabolism. Considering to literature data, variations of thyroid hormones within normal ranges change in obesity and type 2 diabetes mellitus (T2DM) in opposite ways. This study aims to evaluate thyroid hormone levels and fT3/fT4 ratio in different glucose metabolism statuses of euthyroid patients with obesity.Methods</p...

0 shares

Endocrine Abstracts

24-week impact of dapagliflozin treatment on body weight, body composition, and cardiac risk indicators of patients with type-2 diabetes mellitus

Changes in thyroid hormones and free triiodothyronine-to-free thyroxine ratio in euthyroid patients with obesity in terms of different glucose metabolism statuses

BiosciAbstracts